Evidence map›Paper›PMID 41880222›Full record

ReviewJMIR dermatology2026

Beta-Alanine and Aquagenic Pruritus: Proposed Neuroimmune Mechanism.

Natalie Piserchio, Bailey Baratta, Benjamin Brooks, Brandon Muse, Katelin Ball

Abstract readReview
In one paragraph

Review in JMIR dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Natalie PiserchioRocky Vista University, 8401 S Chambers Rd, Englewood, CO, 80112, United States, 1 (303) 373-2008.ORCID 0009-0007-5012-6022
Bailey BarattaInternal Medicine Residency HEB/Denton, Texas Health Resources, Bedford, TX, United States.ORCID 0000-0002-6118-7871
Benjamin BrooksDepartment of Biomedical Sciences, Rocky Vista University, Ivins, UT, United States.ORCID 0000-0001-7456-3074
Brandon MuseDepartment of Obstetrics and Gynecology, Orlando Health, Orlando, FL, United States.ORCID 0009-0005-3031-8006
Katelin BallDepartment of Neurology, University of New Mexico, Albuquerque, NM, United States.ORCID 0009-0002-8585-2095

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Unlabelled: Aquagenic pruritus (AP) is a rare itch disorder with limited effective treatments, and emerging clinical observations suggest that oral β-alanine may reduce symptoms. The purpose of this viewpoint is to propose a biologically plausible mechanism through which β-alanine may alleviate primary AP. We reviewed published case reports and patient-reported survey data describing β-alanine use in AP and integrated these clinical observations with experimental data on MAS-related G protein-coupled receptor D (MrgprD)-expressing sensory neurons and their role in mast-cell regulation. Published case reports describe marked improvement in water-induced pruritus following prophylactic oral β-alanine administration, and a recent survey of patients with idiopathic AP reported substantial symptom relief among β-alanine users. Preclinical data indicate that MrgprD-neuronal glutamate release suppresses mast cell hyperresponsiveness, suggesting a potential pathway for the observed antipruritic effect. Additional mechanisms, including β-alanine metabolism to carnosine and its potential mast cell-stabilizing effects, may also contribute. β-alanine may act through modulation of a nonhistaminergic neuroimmune circuit and represents a promising therapeutic candidate for further investigation in AP.

Indexed as

beta-AlaninePruritusWaterAnimalsHumansMast CellsReceptors, G-Protein-Coupledbeta-AlanineReceptors, G-Protein-CoupledWateraquagenic pruritusbeta-alanineglutamatergic signalingitch modulationMAS-related G protein–coupled receptor Dmast-cell hyperresponsivenessMrgprDneurocutaneous mechanismsneuroimmune signalingnonhistaminergic itchprimary aquagenic prurituspruriceptive pathways

Identifiers

PMID41880222
PMCPMC13015910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.